Retrospective review of the efficacy for sublingual ketamine in the treatment of chronic low back pain defined by a cause and central functional pain symptom focused clinical model

References

• AIo Health Welfare. Australian burden of disease study: impact and causes of illness and death in Australia 2018. Canberra: AIHW, 2021.
   Google Scholar
• Raja SN, Carr DB, Cohen M, et al. The revised international association for the study of pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976–1982.
   PubMed Web of Science ®Google Scholar
• Waddell G. 1987 Volvo award in clinical sciences. A new clinical model for the treatment of low-back pain. Spine. 1987;12(7):632–644.
   PubMed Web of Science ®Google Scholar
• Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;35:80–94.
   Web of Science ®Google Scholar
• Bogduk N. Mechanisms of musculoskeletal pain. J Orthopaed Med. 2006;28(3):113–124.
   Google Scholar
• PainHealth. Pain types - pain management Government of Western Australia Department of Health; 2021.
   Google Scholar
• Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002.
   PubMed Web of Science ®Google Scholar
• Brazenor GA, Malham GM, Teddy PJ. Can Central sensitization after injury persist as an autonomous pain generator? A comprehensive search for evidence. Pain Med. 2022;23(7):1283–1298.
   PubMed Web of Science ®Google Scholar
• Cliton Bezerra M, Valentim Bittencourt J, Reis FJJ, et al. Central sensitization inventory is a useless instrument for detection of the impairment of the conditioned pain modulation in patients with chronic musculoskeletal pain. Joint Bone Spine. 2021;88(3):105127.
   PubMed Web of Science ®Google Scholar
• Neblett R. The central sensitization inventory: a user’s manual. J Appl Behav Res. 2018;23(2):e12123.
   Web of Science ®Google Scholar
• Nijs J, George SZ, Clauw DJ, et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3(5):e383–e92.
   PubMedGoogle Scholar
• Fleiss J, Gurland B, Roche PD. Distinctions between organic brain syndrome and functional psychiatric disorders: based on the geriatric mental state interview. Int J Aging Hum Dev. 1976;7(4):323–330.
   PubMed Web of Science ®Google Scholar
• Dilsaver SC. Differentiating organic from functional psychosis. Am Fam Physician. 1992;45(3):1173–1180.
   PubMed Web of Science ®Google Scholar
• Fine PG. Long-Term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Med. 2011;12(7):996–1004.
   PubMed Web of Science ®Google Scholar
• McBeth J, Harkness EF, Silman AJ, et al. The role of workplace low-level mechanical trauma, posture and environment in the onset of chronic widespread pain. Rheumatology. 2003;42(12):1486–1494.
   PubMed Web of Science ®Google Scholar
• Yunus MB. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat. 2012;2012:584573.
   PubMedGoogle Scholar
• Schug SA, Goddard C. Recent advances in the pharmacological management of acute and chronic pain. Ann Palliat Med. 2014;3(4):263–275.
   PubMedGoogle Scholar
• Wallden M. The neutral spine principle. J Bodyw Mov Ther. 2009;13(4):350–361.
   PubMedGoogle Scholar
• Myer GD, Kushner AM, Brent JL, et al. The back squat: a proposed assessment of functional deficits and technical factors that limit performance. Strength Cond J. 2014;36(6):4–27.
   PubMed Web of Science ®Google Scholar
• Wilke HJ, Neef P, Caimi M, et al. New in vivo measurements of pressures in the intervertebral disc in daily life. Spine. 1999;24(8):755–762.
   PubMed Web of Science ®Google Scholar
• Li W, Gong Y, Liu J, et al. Peripheral and Central pathological mechanisms of chronic low back pain: a narrative review. J Pain Res. 2021;14:1483–1494.
   PubMed Web of Science ®Google Scholar
• Bid D, Soni N, Rathod P. Central sensitization in chronic low back pain: a narrative review. NJIRM. 2016;7:114–123.
   Google Scholar
• Radebold A, Cholewicki J, Polzhofer GK, et al. Impaired postural control of the lumbar spine is associated with delayed muscle response times in patients with chronic idiopathic low back pain. Spine. 2001;26(7):724–730.
   PubMed Web of Science ®Google Scholar
• van Middelkoop M, Rubinstein SM, Kuijpers T, et al. A systematic review on the effectiveness of physical and rehabilitation interventions for chronic non-specific low back pain. Eur Spine J. 2011;20(1):19–39.
   PubMed Web of Science ®Google Scholar
• Johnson D, Hanna J. Why we fail, the long-term outcome of lumbar fusion in the Swedish Lumbar Spine Study. Spine J. 2017;17(5):754.
   PubMed Web of Science ®Google Scholar
• Haslam C, Bertschy K, Cruwys T, et al. The group mechanism in treatment: group identification and cohesion contributes to reducing chronic lower back pain by increasing personal control. Disabil Rehab. 2023;45(8):1332–1342.
   PubMed Web of Science ®Google Scholar
• Smith BE, Littlewood C, May S. An update of stabilisation exercises for low back pain: a systematic review with meta-analysis. BMC Musculoskelet Disord. 2014;15(1):416.
   PubMedGoogle Scholar
• Husi H. NMDA receptors, neural pathways, and protein interaction databases. Int Rev Neurobiol. 2004;61:49–77.
   PubMed Web of Science ®Google Scholar
• McMahon SB, Wall PD. Wall and Melzack’s textbook of pain. 6th ed. Philadelphia, PA: Elsevier/Saunders; 2013.
   Google Scholar
• Liu GL, Cui YF, Lu C, et al. Ketamine a dissociative anesthetic: neurobiology and biomolecular exploration in depression. Chem Biol Interact. 2020;319:109006.
   PubMed Web of Science ®Google Scholar
• Newcomer JW, Farber NB, Olney JW. NMDA receptor function, memory, and brain aging. Dialogues Clin Neurosci. 2000;2(3):219–232.
   PubMedGoogle Scholar
• Chong C, Schug SA, Page-Sharp M, et al. Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: preliminary findings from a three-way randomized, crossover study. Clin Drug Investig. 2009;29(5):317–324.
   PubMed Web of Science ®Google Scholar
• Corriger A, Pickering G. Ketamine and depression: a narrative review. Drug Des Devel Ther. 2019;13:3051–3067.
   PubMed Web of Science ®Google Scholar
• Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747.
   PubMed Web of Science ®Google Scholar
• Humphrey N, Skoyles J, Keynes R. Human hand-walkers: five siblings who never stood up; 2005.
   Google Scholar
• Chan C-W, Peng P. Failed back surgery syndrome. Pain Med. 2011;12(4):577–606.
   PubMed Web of Science ®Google Scholar
• Christelis N, Simpson B, Russo M, et al. Persistent spinal pain syndrome: a proposal for failed back surgery syndrome and ICD-11. Pain Med. 2021;22(4):807–818.
   PubMed Web of Science ®Google Scholar
• Atkinson V, Rubic S. Ketamine infusion (adult—acute setting). Corporate Policy and Procedure. Healthscope, 2019.
   Google Scholar
• Ketamine infusions for adult patients with acute and chronic non-malignant pain (procedure). Royal Hospital for Women; 2013.
   Google Scholar
• Proposal for practice guideline: low dose ketamine infusion in the management of chronic non-cancer pain. Faculty of Pain Medicine ANZCA; 2016.
   Google Scholar